ARTICLE | Clinical News
Genzyme data
May 10, 1993 7:00 AM UTC
GENZ will file for FDA approval shortly and expects rGCR to be commercially available by late 1994 or early 1995. The price of the drug will be determined then. The annual cost per patient of Ceredase...